Jeremy Shinoda

Cordant Health Solutions

Quality Compliance Analyst

United States

http://www.cordantsolutions.com

  • Cordant Health Solutions

SCHOLARLY PAPERS

6

DOWNLOADS

0

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (6)

Actions:
Email selected abstracts
1.

Interferon α2b Gene Delivery Using Adenoviral Vector Causes Inhibition of Tumor Growth in Xenograft Models from a Variety of Cancers

Cancer Gene Therapy volume 8, pages 788–795 (2001)
Posted: 17 Apr 2019
Jeremy Shinoda
Cordant Health Solutions

Abstract:

Loading...

gene therapy, IACB, interferon α2b, glioblastoma, tumor suppression

2.

Adenovirus-Mediated Gene Therapy Using Human p21WAF-1/Cip-1 to Prevent Wound Healing in a Rabbit Model of Glaucoma Filtration Surgery

Arch Ophthalmol. 2002;120(7):941-949. doi:10.1001/archopht.120.7.941
Posted: 17 Apr 2019
Jeremy Shinoda
Cordant Health Solutions

Abstract:

Loading...

gene therapy, glaucoma filtration surgery, p21, mitomycin, wound healing

3.

Assessment of p53 Gene Transfer and Biological Activities in a Clinical Study of Adenovirus-p53 Gene Therapy for Recurrent Ovarian Cancer

Cancer Gene Therapy volume 10, pages 224–238 (2003), DOI10.1038/sj.cgt.7700562
Posted: 17 Apr 2019
Jeremy Shinoda
Cordant Health Solutions

Abstract:

Loading...

gene therapy, cancer, p53, p21

4.

Adenoviral Delivery of Human and Viral IL-10 in Murine Sepsis

J Immunol July 15, 2001, 167 (2) 1053-1059
Posted: 15 Apr 2019
Jeremy Shinoda
Cordant Health Solutions

Abstract:

Loading...

gene therapy, inflammation, IL-10

5.

Biological Activities of a Recombinant Adenovirus P53 (Sch 58500) Administered by Hepatic Arterial Infusion in a Phase 1 Colorectal Cancer Trial

Posted: 10 May 2018
Jeremy Shinoda, Shu Fen Wen and Dan Maneval
Cordant Health Solutions, Canji, Inc. - Department of Process Sciences and Canji, Inc. - Department of Pharmacology

Abstract:

Loading...

6.

Specific Depletion of Human Anti-Adenovirus Antibodies Facilitates Transduction in an in Vivo Model for Systemic Gene Therapy

Molecular Therapy, Vol. 3, Issue 5, May 2001
Posted: 19 Apr 2018
Amena Rahman, Van Tsai, Ann Goudreau, Jeremy Shinoda, Shu Fen Wen, Muralidhara Ramachandra, Rob Ralston, Dan Maneval, Drake LaFace and Paul Shabram
Canji, Inc. - Department of Molecular Biology, Canji, Inc. - Department of Pharmacology, Canji, Inc. - Department of Molecular Biology, Cordant Health Solutions, Canji, Inc. - Department of Process Sciences, Canji, Inc. - Department of Molecular Biology, Canji, Inc. - Department of Molecular Biology, Canji, Inc. - Department of Pharmacology, Canji, Inc. - Department of Pharmacology and Canji, Inc. - Department of Process Sciences

Abstract:

Loading...

recombinant adenovirus, neutralizing antibodies, capsid columns, immunopheresis, transduction efficiency, β-galactosidase rAd-vector, empty rAd-vector, green fluorescent protein rAd-vector, depletion